Semaglutide Lowers Risk of COVID Death
Research has found that people taking GLP-1 weight-loss drugs had significantly lower risk of death from COVID-19 and other infectious and cardiovascular causes.
Read More...Latest Clinical & Research News
Specialty: Gastroenterology & GI Surgery
Research has found that people taking GLP-1 weight-loss drugs had significantly lower risk of death from COVID-19 and other infectious and cardiovascular causes.
Read More...A Brigham and Women’s Hospital research team established baseline epidemiological information about a new paradigm called cardiovascular, kidney, and metabolic (CKM) syndrome.
Read More...Gary W. Liu, PhD, Giovanni Traverso, MD, PhD, MBBCH, of the Division of Gastroenterology, Hepatology and Endoscopy at Brigham and Women’s Hospital, and colleagues show how a drinkable formulation called LIFT hydrogels could expand access to advanced therapeutics for people who have trouble swallowing pills.
Read More...A Brigham and Women’s Hospital study suggests endoscopic sleeve gastroplasty (ESG) is cost-saving compared with semaglutide for class II obesity due to greater effectiveness and lower costs of ESG and increased dropout rates over time with semaglutide.
Read More...Namrata Patil, MD, MPH, Anupama Singh, MD, and team compared thoracic epidural analgesia with injection of liposomal bupivacaine (LB) under direct witness in patients undergoing minimally invasive lung resection. LB intercostal block reduced opioid use 48 hours postoperatively and had fewer postoperative complications.
Read More...Brigham and Women’s Hospital researchers and colleagues hypothesized that central adiposity, not elevated BMI alone, may have a role in fecal incontinence (FI). They report that waist circumference-to-height ratio (WtHR) is a stronger predictor of FI than BMI.
Read More...Throughout his career, new Brigham gastrointestinal surgeon O. Yusef Kudsi, MD, MBA, has embodied an entrepreneurial spirit most often seen in the business world. That characteristic helped him develop an international reputation as a hernia surgeon and a pioneer in robotic procedures for abdominal wall reconstruction.
Read More...A recent pooled analysis of randomized trials co-led by Brigham and Women’s Hospital researchers indicates that patients with type 2 diabetes who underwent bariatric surgery achieved better long-term blood glucose control compared to patients who received medical management plus lifestyle interventions.
Read More...Members of the Brigham’s Department of Surgery served as authors of three recently published retrospective studies focused on bariatric surgery. Eric G. Sheu, MD, PhD, section chief of Bariatric and Foregut Surgery, and surgery resident Tina Bharani, MD, discuss the key clinical implications.
Read More...Brigham researchers conducted a first-of-its-kind retrospective study to better understand the subset of bariatric surgery patients who do not comply with recommended follow-ups that would help optimize long-term outcomes. Ali Tavakkoli, MD, chief of the Division of General and GI Surgery, discusses their findings.
Read More...